Home › NDC Lookup › RxCUI directory › RxCUI 1670316

Tipiracil 8.19 MG / trifluridine 20 MG Oral Tablet — RxCUI 1670316

RxNorm drug concept · Semantic clinical drug
RxCUI 1670316 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1670316
Official nameTipiracil 8.19 MG / trifluridine 20 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped2
Package NDCs mapped6
Reported Medicaid activity (SDUD)1,725 prescriptions · 16 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Trifluridine and Tipiracil: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Lonsurf is a chemotherapy medication used when colorectal cancer or stomach/esophageal junction cancer has spread and other treatments have already been tried. It's not a first-lin...
  • What exactly is Lonsurf treating, and why am I on it?
  • Not every single day — Lonsurf follows a cycle. You take it twice a day with food for 5 days in a row, take 2 days off, then take it again for another 5 days, then you get about 2...
  • How do I take this medication — do I take it every day?
📖 Read our full Trifluridine and Tipiracil guide →

🕸️ Concept Web — How Tipiracil 8.19 MG / trifluridine 20 MG Oral Tabl... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Tipiracil 8.19 MG / trifluridine 20 MG Oral Tablet RxCUI 1670316

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Tipiracil 1670304
    • Trifluridine 10803
    • Tipiracil / trifluridine 1670310
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Lonsurf 1670317
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Tipiracil / trifluridine Oral Tablet 1670309
    • Tipiracil / trifluridine Oral Product 1670307
    • Tipiracil / trifluridine Pill 1670308
    • Tipiracil / trifluridine Oral Tablet [Lonsurf] 1670319
    • Lonsurf Oral Product 1670320
    • Lonsurf Pill 1670321
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Tipiracil 8.19 MG SCDC · 1670314
  • Trifluridine 20 MG SCDC · 1670315
  • Tipiracil / trifluridine Oral Tablet SCDF · 1670309
  • Tipiracil / trifluridine Oral Product SCDG · 1670307
  • Tipiracil / trifluridine Pill SCDG · 1670308

Brand-Name Concepts

📦 FDA Products & Package NDCs

2 products · 6 package NDCs
6 package NDCs map to RxCUI 1670316 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
64842-1020-01 20 TABLET, FILM COATED in 1 BOTTLE (64842-1020-1) LONSURF Taiho Pharmaceutical Co., Ltd. 2015-10-07
64842-1020-02 40 TABLET, FILM COATED in 1 BOTTLE (64842-1020-2) LONSURF Taiho Pharmaceutical Co., Ltd. 2015-11-11
64842-1020-03 60 TABLET, FILM COATED in 1 BOTTLE (64842-1020-3) LONSURF Taiho Pharmaceutical Co., Ltd. 2015-10-21
64842-1025-01 20 TABLET, FILM COATED in 1 BOTTLE (64842-1025-1) LONSURF Taiho Pharmaceutical Co., Ltd. 2015-10-07
64842-1025-02 40 TABLET, FILM COATED in 1 BOTTLE (64842-1025-2) LONSURF Taiho Pharmaceutical Co., Ltd. 2015-11-11
64842-1025-03 60 TABLET, FILM COATED in 1 BOTTLE (64842-1025-3) LONSURF Taiho Pharmaceutical Co., Ltd. 2015-10-21
Observed labelers: Taiho Pharmaceutical Co., Ltd. (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.